These platforms can protect peptides from degradation, target them to specific tissues or immune cell populations, and provide sustained release over extended periods
Compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), while tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan, with both available nationwide across all 50 states
Other serious risks include pancreatitis, gallbladder disease, acute kidney injury, hypoglycemia (when used with insulin or insulin secretagogues), and diabetic retinopathy complications
It is investigational and is being studied in Eli Lilly's Phase 3 TRIUMPH (obesity-focused) and TRANSCEND-T2D (type 2 diabetes) programs
Traces for ~2000 particles were recorded and averaged
In a trial, people lost an average of 8.4% of their body weight in a year on the maximum dose